- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01214707
Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy
March 13, 2012 updated by: Cyberonics, Inc.
Characterization of the cardiac response (ECG) preceding an epileptic seizure.
Study Overview
Detailed Description
Characterization of the cardiac response (ECG) to physiologic events and comparison to changes in heart rate that precede an epileptic seizure.
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85013
- BNI
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- KUMC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adults with epilepsy already scheduled for an EMU stay.
Description
Inclusion Criteria:
- Patient has a clinical diagnosis of epilepsy requiring additional evaluation in an epilepsy monitoring unit (EMU).
- Patient likely requires an EMU evaluation for a period of at least 3 days.
- In the opinion of the Principal Investigator, the Patient is likely to have 3 - 5 seizures during the EMU stay.
- Patient is currently taking at least one antiepileptic medication.
- Patients must be 18 years or older and may be of either sex and of any race.
- Patient must be in good general health, fully ambulatory, and able to complete the physical aspects of testing requirements.
- Patient must be willing and able to complete informed consent and HIPAA authorization.
- Patient is diagnosed with epilepsy but may also experience pseudo seizures or psychogenic seizures.
Exclusion Criteria:
- Patients with severe psychiatric disease that in the investigator's judgment would prevent the patient's successful completion of the study.
- Patients experiencing status epileptic within the last 6 months.
- Patients with cardiovascular, respiratory, neuromuscular or gait disorders that in the investigator's judgment would cause unnecessary risk.
- Patients prescribed drugs specifically for a cardiac or autonomic disorder that in the investigator's opinion would affect heart rate response. Drugs with secondary cardiac or autonomic actions are allowed.
- Patients with cardiovascular arrhythmias or cardiac disease that would preclude the ability to detect intrinsic changes in heart rate due to exercise, stress, or seizure. This would include but not be limited to chronic atrial fibrillation and permanent cardiac pacemaker implantation.
- Patients currently dependent on alcohol or narcotic drugs as defined by DSM IV-R.
- Patients with a history of only psychogenic seizures or pseudo seizures.
- Women who are pregnant. Women of childbearing age must take a pregnancy test.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Exercise protocol
No arms are required for this study as all subjects complete the entire protocol
|
Exercise during EMU stay
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Rate Changes during Normal Activity, Exercise, and Seizures in Subjects with Epilepsy
Time Frame: 3 to 5 days
|
Characterization of the cardiac response (ECG) to physiologic events and comparison to changes in heart rate that precede an epileptic seizure.
|
3 to 5 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David M Treiman, MD, Barrow Neurological Institute Phoenix AZ
- Principal Investigator: Ivan Osorio, MD, KUMC Kansas City, Kansas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
October 1, 2011
Study Registration Dates
First Submitted
October 1, 2010
First Submitted That Met QC Criteria
October 4, 2010
First Posted (Estimate)
October 5, 2010
Study Record Updates
Last Update Posted (Estimate)
March 15, 2012
Last Update Submitted That Met QC Criteria
March 13, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-31
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
University Hospital, LilleCompletedFocal Epilepsy | Epilepsy IntractableFrance
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustNot yet recruitingEpilepsy Intractable | Epilepsy in Children
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsRecruitingEpilepsy, Drug ResistantChina
-
Aston UniversityBirmingham Women's and Children's NHS Foundation TrustEnrolling by invitationEpilepsy in Children | Epilepsy in Youth | Epilepsy (Treatment Refractory)United Kingdom
-
LivaNovaWithdrawnEpilepsy, Tonic-ClonicBelgium
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting
-
University of Missouri-ColumbiaCompleted
-
University of AlcalaCompletedMyofascial Pain | Myofascial Pain Syndrome | Post Needling Soreness | Myofascial Trigger Point PainSpain
-
University College CorkRecruitingDepressive Disorder, MajorIreland
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of